A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia-Reference-Cited by-同舟云学术

A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia

Published:2023-06-08 Issue:3 Volume:10 Page:471-480
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Lin Dee,Pilon Dominic^ORCID,Morrison Laura,Shah Aditi,Lafeuille Marie-Hélène,Lefebvre Patrick,Benson Carmela

Funder

Janssen Scientific Affairs, LLC

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-023-00376-0.pdf

Reference37 articles.

1. Desai PR, Lawson KA, Barner JC, et al. Estimating the direct and indirect costs for community-dwelling patients with schizophrenia. J Pharm Health Serv Res. 2013;4(4):187–94. https://doi.org/10.1111/jphs.12027.

2. Wu EQ, Shi L, Birnbaum H, et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med. 2006;36(11):1535–40. https://doi.org/10.1017/S0033291706008191.

3. National Alliance on Mental Illness. Mental Health By the Number Arlington, VA. 2021. https://www.nami.org/mhstats. Accessed 28 Sept 2021.

4. Schizophrenia & Psychosis Action Alliance. Societal costs of schizophrenia & related disorders. 2021. https://sczaction.org/wp-content/uploads/2021/11/571-012_WhitePaper_Report_FINAL_updated_11.09.21.pdf. Accessed 28 Sept 2021.

5. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia—Third Edition. 2019. https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/Clinical%20Practice%20Guidelines/APA-Draft-Schizophrenia-Treatment-Guideline-Dec2019.pdf. Accessed 28 Sept 2021.